IL152725A0 - Human receptor proteins, related reagents and methods - Google Patents

Human receptor proteins, related reagents and methods

Info

Publication number
IL152725A0
IL152725A0 IL15272501A IL15272501A IL152725A0 IL 152725 A0 IL152725 A0 IL 152725A0 IL 15272501 A IL15272501 A IL 15272501A IL 15272501 A IL15272501 A IL 15272501A IL 152725 A0 IL152725 A0 IL 152725A0
Authority
IL
Israel
Prior art keywords
methods
receptor proteins
human receptor
related reagents
reagents
Prior art date
Application number
IL15272501A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL152725A0 publication Critical patent/IL152725A0/xx

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02D—CONTROLLING COMBUSTION ENGINES
    • F02D11/00—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated
    • F02D11/06—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated characterised by non-mechanical control linkages, e.g. fluid control linkages or by control linkages with power drive or assistance
    • F02D11/10—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated characterised by non-mechanical control linkages, e.g. fluid control linkages or by control linkages with power drive or assistance of the electric type
    • F02D11/106—Detection of demand or actuation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02D—CONTROLLING COMBUSTION ENGINES
    • F02D11/00—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated
    • F02D11/06—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated characterised by non-mechanical control linkages, e.g. fluid control linkages or by control linkages with power drive or assistance
    • F02D11/10—Arrangements for, or adaptations to, non-automatic engine control initiation means, e.g. operator initiated characterised by non-mechanical control linkages, e.g. fluid control linkages or by control linkages with power drive or assistance of the electric type
    • F02D11/107—Safety-related aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Combustion & Propulsion (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15272501A 2000-05-25 2001-05-23 Human receptor proteins, related reagents and methods IL152725A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20755800P 2000-05-25 2000-05-25
PCT/US2001/016766 WO2001090151A2 (fr) 2000-05-25 2001-05-23 Proteines receptrices humaines, reactifs et methodes associes

Publications (1)

Publication Number Publication Date
IL152725A0 true IL152725A0 (en) 2003-06-24

Family

ID=22771074

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15272501A IL152725A0 (en) 2000-05-25 2001-05-23 Human receptor proteins, related reagents and methods
IL192111A IL192111A0 (en) 2000-05-25 2008-06-12 Human receptor proteins; related reagents and methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL192111A IL192111A0 (en) 2000-05-25 2008-06-12 Human receptor proteins; related reagents and methods

Country Status (13)

Country Link
EP (4) EP1433792A3 (fr)
JP (1) JP2003533996A (fr)
KR (1) KR100907356B1 (fr)
CN (2) CN1721443A (fr)
AU (3) AU6488901A (fr)
CA (1) CA2410082A1 (fr)
HK (1) HK1049017A1 (fr)
HU (1) HUP0302240A2 (fr)
IL (2) IL152725A0 (fr)
MX (1) MXPA02011618A (fr)
NZ (2) NZ534666A (fr)
WO (1) WO2001090151A2 (fr)
ZA (1) ZA200208856B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
JP2002034565A (ja) 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
CN1633598A (zh) * 2001-10-05 2005-06-29 科勒制药股份公司 Toll样受体3信号传导的激动剂和拮抗剂
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
DK1773872T3 (en) * 2004-05-21 2017-05-08 Uab Res Found VARIABLE Lymphocyte Receptors, Associated Polypeptides and Nucleic Acids, and Uses thereof
WO2006025995A2 (fr) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions et methodes faisant intervenir des mutants md-2 et des proteines chimeres
EP1657257A1 (fr) * 2004-11-11 2006-05-17 Klinikum der Universität Regensburg Protéines de fusion recombinantes de TLR-MD-2
CA2587676A1 (fr) 2004-11-19 2006-05-26 Institut Gustave Roussy Traitement ameliore du cancer par arn double brin
UA97229C2 (ru) * 2004-11-30 2012-01-25 Центокор, Инк. Изолированное моноклональное антитело, которое специфически связывается с toll-подобным рецептором 3 (tlr3)
US7498409B2 (en) 2005-03-24 2009-03-03 Schering Corporation Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
US7700728B2 (en) 2005-03-24 2010-04-20 Schering Corporation Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
WO2009086352A2 (fr) * 2007-12-26 2009-07-09 Centocor, Inc. Récepteur de type toll 3 de cynomolgus
TWI481401B (zh) 2010-01-27 2015-04-21 Takeda Pharmaceutical 藥劑
CA2837227C (fr) 2011-06-01 2022-05-10 Janus Biotherapeutics, Inc. Nouveaux modulateurs du systeme immunitaire
WO2012167053A1 (fr) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Nouveaux modulateurs du système immunitaire
CA2850932A1 (fr) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Nouveaux modulateurs du systeme immunitaire a base d'imidazole quinoline
BR112020021266A2 (pt) 2018-05-31 2021-01-26 Daiichi Sankyo Company, Limited anticorpo anti-tlr7 humano
KR102265432B1 (ko) * 2019-08-20 2021-06-15 주식회사 케어젠 피부 미백 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (fr) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4215149A (en) 1978-11-17 1980-07-29 Standard Brands Incorporated Process for improving the palatability of pet food
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
ES2331622T3 (es) * 1997-05-07 2010-01-11 Schering Corporation Proteinas receptoras humanas similares a toll, reactivos y metodos relacionados.
PT1887014E (pt) * 1997-10-17 2010-07-05 Genentech Inc Homëlogos de toll humana
JP2000128900A (ja) * 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
EP1320598A2 (fr) * 2000-02-24 2003-06-25 Incyte Genomics, Inc. Polypeptides et molecules correspondants pour la detection et la traitement de maladies

Also Published As

Publication number Publication date
AU2006222684B2 (en) 2008-12-11
KR20030003761A (ko) 2003-01-10
CN1721443A (zh) 2006-01-18
AU2006222684A1 (en) 2006-10-19
KR100907356B1 (ko) 2009-07-10
NZ522327A (en) 2004-09-24
AU6488901A (en) 2001-12-03
MXPA02011618A (es) 2003-03-10
EP1714980A1 (fr) 2006-10-25
WO2001090151A3 (fr) 2002-10-17
JP2003533996A (ja) 2003-11-18
EP1283849A2 (fr) 2003-02-19
ZA200208856B (en) 2004-03-24
HK1049017A1 (zh) 2003-04-25
EP1433792A2 (fr) 2004-06-30
CA2410082A1 (fr) 2001-11-29
NZ534666A (en) 2006-01-27
EP1433792A3 (fr) 2004-11-17
WO2001090151A2 (fr) 2001-11-29
IL192111A0 (en) 2008-12-29
CN1222539C (zh) 2005-10-12
EP1433792A8 (fr) 2004-10-06
EP1908837A2 (fr) 2008-04-09
AU2009200539A1 (en) 2009-03-05
HUP0302240A2 (hu) 2003-10-28
CN1444602A (zh) 2003-09-24
EP1908837A3 (fr) 2008-06-11

Similar Documents

Publication Publication Date Title
IL192111A0 (en) Human receptor proteins; related reagents and methods
HUP0302339A3 (en) Mammalian receptor subunit proteins, related reagents and methods
AU2001246905A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
ZA200205485B (en) Human and parasite orphan receptor proteins.
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU2001260691A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU5258601A (en) Novel g protein-coupled receptor protein and dna thereof
EG22900A (en) Diagnostic reagents and preparing methods thereof
AU2001269462A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU8229901A (en) Genes and proteins, and their uses
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001274522A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001269520A1 (en) Novel g protein-coupled receptor protein and dna thereof
GB2364057A8 (en) G protein coupled receptor
AU2001242800A1 (en) Novel g protein-coupled receptor protein and dna thereof
GB0013345D0 (en) Modified receptor and assay
GB0030059D0 (en) Polypeptides, methods and means
GB0105922D0 (en) Genes and proteins, and their use
AU2001267884A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001271025A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001280118A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001248755A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2001267898A1 (en) Novel g protein-coupled receptor protein and dna thereof
GB0010191D0 (en) Assays, methods and means